Jeff Closs Email and Phone Number
Jeff Closs work email
- Valid
- Valid
- Valid
- Valid
- Valid
Jeff Closs personal email
Jeff Closs phone numbers
Accomplished senior executive with extensive experience in healthcare. Proven track record in large corporate and start-up environments. Successfully developed product concepts and business strategy and carried them through to revenue/profitability. Experienced in strategy, M&A, sales, marketing, software and product development, and operations.INDUSTRY EXPERIENCESoftware-as-a-ServiceHealthcare ExchangesHealthcare EconomicsBenefits, HR and PayrollHealth InsuranceHealth PlansInsurance BrokerageMedical DevicesDigital HealthJeff Closs was a co-founder, President and CEO of Benu/syncHR. BENU is leading innovator for healthcare exchanges and cloud-based human resources, benefits, and payroll software. Prior to co-founding BENU, Jeff was President and CEO at Fox Hollow Technologies, Inc., a leading cardiovascular device company. Previously, Jeff was Vice President and International General Manager for Perclose, where he was part of the senior executive team that led the company from early formation through a successful IPO and ultimately an acquisition by Abbott Laboratories. Prior to Perclose, Jeff held positions in a variety of functional areas including marketing, sales, clinical, regulatory, manufacturing and international operations with Devices for Vascular Intervention/Guidant and Bentley/Edwards divisions of Baxter Healthcare Corporation. Jeff has testified before the Joint Economic Committee of the U.S Congress on Healthcare reform. He is a currently on the Board of Directors for BioIQ and Snoozley He is a former director, member of the Nominating and Governance committee and Chair of the Audit committee of Nellix Endovascular an Essex Woodlands Health Ventures portfolio company, which was sold to Endologix. He is an Adjunct Associate at Stanford University Center for Health Policy. He is also a past president of the St. Raymond School Board. Jeff received his MBA from Emory University and his BA from the University of California, Los Angeles.
Ancora Heart, Inc.
View- Website:
- ancoraheart.com
- Employees:
- 75
-
President And CeoAncora Heart, Inc. Nov 2015 - PresentAncora Heart, a medical device company based in Santa Clara, Calif., is dedicated to helping people with heart failure (HF) and functional mitral regurgitation (FMR) feel better and live longer.The company has developed AccuCinch®, the first percutaneous ventricular repair (PVR) system designed to treat FMR, which is caused by heart failure. AccuCinch targets dysfunction of the left ventricle, which is the underlying cause of FMR. Unlike current surgical or transcatheter procedures that replace or repair an otherwise-normal mitral valve, AccuCinch repairs the left ventricle to reduce FMR and improve quality of life for heart failure patients.
-
Chairman Of The BoardSnoozely Aug 2015 - Dec 2016Digital health Incubator working on novel technology and software for Obstructive Sleep Apnea
-
Member Of Board Of DirectorsBioiq 2010 - Dec 2016BioIQ (http://www.BioIQ.com) is a healthcare technology company that enables organizations to connect with their populations, measure vital health metrics, and achieve health improvement goals. BioIQ works with some of the largest employers and health companies in the nation. Since its inception in 2005, it has launched thousands of successful health improvement programs serving millions of participants.
-
Entrepreneur In ResidenceThe Angels' Forum Sep 2015 - Dec 2015Mountain View, Ca, UsThe Angels’ Forum (TAF) is an experienced and engaged group of investors focused on making money from investments in Silicon Valley. Since forming in 1997, TAF has become one of the most respected angel groups in the San Francisco Bay Area. All members have made their own wealth from previous entrepreneurial ventures and/or corporate experience -
Member Of The Board Of DirectorsBenu/Synchr 2000 - Oct 2015UsSyncHR is a leading innovator for cloud-based human resources, benefits, and payroll software. SyncHR reinvents how employers manage human capital with an event-driven single application. SyncHR’s patented single database system creates transparency company-wide, improves data integrity and grows as you expand. A BENU subsidiary, syncHR has offices in Oakland, California and Sofia, Bulgaria. -
Co-Founder, President & CeoBenu/Synchr Sep 2000 - May 2015UsCo-founded Benu with New Enterprise Associates, focusing on healthcare. Benu conceptualized, built and operated the first multi-carrier risk adjusted healthcare exchange with national payers (Kaiser, United Healthcare, CIGNA). Identified a unique opportunity to expand consumer choice in healthcare insurance pre-Obama Care e.g healthcare exchanges. Developed a proprietary health risk-adjustment and premium re-allocation model using member pharmacy data. Created strategic partnerships with national health plans. Developed and implemented all operational software, systems, procedures and service models. Developed and implemented unique distribution channels with health plans and brokers. Carrier-sponsored exchanges operated in California, Mid-Atlantic, Oregon and Washington and Broker-sponsored exchange operated in California. Made two acquisitions to bring in additional technology and capabilities. Grew business from inception to over 700 clients representing 170,000 employees. Processed $500 million in health insurance premiums annually with 100% accuracy. Annual revenue of $9 Million in 2014 and reached profitability prior 3 years.Recognized a new strategic opportunity to integrate payroll and HR management into the existing healthcare exchange and benefits administration offering by acquiring syncHR in 2013. Based on market opportunity, sold the healthcare exchange and benefits administration business in early 2015 and repositioned the company to focus on the payroll/HR/benefits syncHR platform.
-
Member Of The Board Of DirectorsNellix, Inc. Sep 2008 - Oct 2010Nellix, Inc, was privately-held medical device company that developed a revolutionary endograft for the treatment of Abdominal Aortic Aneurysms (AAAs). Nellix developed a highly differentiated technology platform that completely seals and fills an aortic aneurysm sac, preventing device migration and potentially improving clinical outcomes. This allows the product to treat a wide range of AAA anatomies, including those that are outside of the indications for existing Endovascular Aortic Repair (EVAR) devices. Nellix was acquired by Endologix, Inc. (Nasdaq: ELGX) in October 2010.
-
President & CeoFoxhollow Technologies Jul 1997 - Mar 2000UsResponsible for all activities of start-up stage, venture backed company. The company developed a novel device for the treatment of peripheral and coronary artery disease. -
Vice President, InternationalPerclose, Inc. Apr 1996 - Jun 1997Responsible for all outside the U.S. sales, marketing, regulatory, reimbursement & clinical activities.
-
Vice President, General Manager - EuropePerclose, Inc. Jan 1994 - Apr 1996Responsible for all European start up operations in manufacturing, regulatory, sales, marketing and clinical. Responsible for CE mark clinical study, including trial design, protocol and data analysis. Identified and started manufacturing operations in Scotland. Conducted early clinical device evaluations with key thought leaders in Europe. Hired direct sales, marketing and clinical teams in UK, France and Germany. Set-up distribution partners in non-direct European countries.
-
Sales And Marketing Manager - Europe, Middle East And AfricaDevices For Vascular Intervention Inc. Apr 1992 - Jan 1994Relocated to London, UK in newly created position to develop and penetrate European market for Directional Coronary Atherectomy. Responsible for European marketing strategy, sales plan and clinical support. Managed distributor network. Transitioned from distributor organizations in France and U.K. to direct DVI organizations. -
Territory ManagerDevices For Vascular Intervention Inc. Jun 1991 - Mar 1992Managed new product introduction of a innovative interventional cardiology therapy. Trained physicians and hospitals in Georgia, North & South Carolina and North Florida on clinical procedure of Directional Coronary Atherectomy. Finished 1st for total dollar increase and 2nd for % sales increase.
-
Regional Manager - Southeast U.S. RegionBaxter Healthcare - Bentley Labs Division Nov 1988 - May 1991Managed five District Managers in the Southeast region which included Alabama, Florida, Georgia, Carolina's, Maryland, Virginia, Washington D.C. and Eastern Pennsylvania. Managed sales plan of $17 million and operating budget of $1 million. Region finished 1st in company at 108% of plan and largest total revenue.
-
Manager, Sales Development And Training ProgramsBaxter International Inc. - Bentley Labs Division Jan 1988 - Oct 1988Appointed to a newly created program and position. Responsible for recruiting new sales associates. Created, developed and conducted a sales training program for sales associates. Developed and conducted sales training programs for the field national sales organization.
-
District ManagerBaxter International Inc. - Bentley Labs Division Jun 1985 - Dec 1987Responsible for sales and clinical support of Bentley Labs cardiovascular bypass and surgery products and Edwards Labs tissue and mechanical heart valves. President’s Club member every year. Converted largest non-Bentley account Johns Hopkins Hospital to 100% Bentley products. Johns Hopkins Hospital became the largest revenue account in company history. Territory included Maryland, Virginia and Washington D.C.
-
Sales AssociateBaxter International Inc. - Bentley Labs Division Jan 1985 - May 1985Bentley Labs division was a leader in Cardiopulmonary bypass devices and heart valves. Successfully completed sales and clinical training program for District Sales Manager. Assigned to the Mid-Atlantic territory based in Washington D.C.
Jeff Closs Skills
Jeff Closs Education Details
-
Emory University - Goizueta Business SchoolMaster Of Business Administration (M.B.A.) -
UclaBachelor Of Arts (B.A.)
Frequently Asked Questions about Jeff Closs
What company does Jeff Closs work for?
Jeff Closs works for Ancora Heart, Inc.
What is Jeff Closs's role at the current company?
Jeff Closs's current role is President and CEO at Ancora Heart, Inc..
What is Jeff Closs's email address?
Jeff Closs's email address is jm****@****ell.net
What is Jeff Closs's direct phone number?
Jeff Closs's direct phone number is +165024*****
What schools did Jeff Closs attend?
Jeff Closs attended Emory University - Goizueta Business School, Ucla.
What are some of Jeff Closs's interests?
Jeff Closs has interest in Education.
What skills is Jeff Closs known for?
Jeff Closs has skills like Leadership And Strategy, M And A Transactions, Venture And Debt Fund Raising, Product Innovation, Strategic Partnerships, Client Services, Operations Management, Sale And Sales Management, Marketing Strategy, Software Development, Clinical Trials, Regulatory Affairs.
Who are Jeff Closs's colleagues?
Jeff Closs's colleagues are Corey Kearby, Pharm.d., Joshua Ogundiran, Vivian Wilson, Roberta Franzese Bsn, Rn, Mba, Ccra, Matthew Yee, Frank Loria, Denise Gutierrez.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial